Lipopolysaccharides from Escherichia coli O55:B5
Catalog number: B2015168
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 1 mg
Molecular Weight or Concentration: N/A
Supplied as: Powder
Applications: a molecular tool for various biochemical applications
Storage: 2 – 8 °C
Keywords: LPS
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1: Bergstrand A, Svanberg C, Langton M, Nydén M. Aggregation behavior and size of lipopolysaccharide from Escherichia coli O55:B5 Colloids Surf B Biointerfaces. 2006 Nov 1;53(1):9-14.
2: Dixon DR, Karimi-Naser L, Darveau RP, Leung KP. The anti-endotoxic effects of the KSL-W decapeptide on Escherichia coli O55:B5 and various oral lipopolysaccharides J Periodontal Res. 2008 Aug;43(4):422-30.
3: Wu X, Gao Y, Shi C, Tong J, Ma D, Shen J, Yang J, Ji M. Complement C1q drives microglia-dependent synaptic loss and cognitive impairments in a mouse model of lipopolysaccharide-induced neuroinflammation Neuropharmacology. 2023 Oct 1;237:109646.
4: Takayama S, Hashimoto K, Kokubu E, Taniguchi M, Tajima K, Ochiai A, Saitoh E, Saito A, Ishihara K, Kato T. Inhibitory effects of a novel cationic dodecapeptide [CL(14-25)] derived from cyanate lyase of rice on endotoxic activities of LPSs from Escherichia coli and periodontopathic Aggregatibacter actinomycetemcomitans Microb Pathog. 2016 May;94:2-11.
5: Vorobeva EV, Krasikova IN, Solov’eva TF. Influence of lipopolysaccharides and lipids A from some marine bacteria on spontaneous and Escherichia coli LPS-induced TNF-alpha release from peripheral human blood cells Biochemistry (Mosc). 2006 Jul;71(7):759-66.
6: Dogan MD, Ataoglu H, Akarsu ES. Effects of different serotypes of Escherichia coli lipopolysaccharides on body temperature in rats Life Sci. 2000 Sep 29;67(19):2319-29.
7: Chalmeh A, Badiei K, Pourjafar M, Nazifi S. Anti-inflammatory effects of insulin regular and flunixin meglumine on endotoxemia experimentally induced by Escherichia coli serotype O55:B5 in an ovine model Inflamm Res. 2013 Jan;62(1):61-7.
8: Kishi K, Hirai K, Hiramatsu K, Yamasaki T, Nasu M. Clindamycin suppresses endotoxin released by ceftazidime-treated Escherichia coli O55:B5 and subsequent production of tumor necrosis factor alpha and interleukin-1 beta Antimicrob Agents Chemother. 1999 Mar;43(3):616-22.
9: Emmanuel DG, Madsen KL, Churchill TA, Dunn SM, Ametaj BN. Acidosis and lipopolysaccharide from Escherichia coli B:055 cause hyperpermeability of rumen and colon tissues J Dairy Sci. 2007 Dec;90(12):5552-7.
10: Peterson AA, McGroarty EJ. High-molecular-weight components in lipopolysaccharides of Salmonella typhimurium, Salmonella minnesota, and Escherichia coli J Bacteriol. 1985 May;162(2):738-45.

Products Related to Lipopolysaccharides from Escherichia coli O55:B5 can be found at Chemicals